Development of Human Motor Skills and the Promotion of Motivation for Physical Activity

March 16, 2026 updated by: Charles University, Czech Republic

University Centre of Excellence for Studies of Human Motoric at Faculty of Physical Education and Sport

This study is conducted within the University Centre of Excellence for Studies of Human Motoric at the Faculty of Physical Education and Sport, Charles University. The project focuses on research investigating mechanisms that support motivation for participation in physical activity among children and youth. In recent decades, participation in physical activity has been declining globally, including among children and adolescents. Understanding the factors that influence motivation for physical activity is essential for developing effective strategies to support long-term engagement in physical activity. The study aims to contribute to knowledge about the role of physical activity and physical education in promoting children's long-term physical and mental development.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Active, not recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
325

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Czechia
    • Czechia
      • Brno, Czechia, Czechia, 635 00
        • ZŠ Laštůvkova
      • Brno, Czechia, Czechia
        • ZŠ Heyrovského
      • Lomnice, Czechia, Czechia, 356 01
        • ZŠ Lomnice
      • Mohelnice, Czechia, Czechia, 789 85
        • ZŠ Mlýnská
      • Pilsen, Czechia, Czechia, 301 00
        • ZŠ Plzeň - Růžovka
      • Prague, Czechia, Czechia, 182 00
        • ZŠ Žernosecká
      • Prague, Czechia, Czechia, 18600
        • ZŠ Lyčkovo náměstí
      • Rudná, Czechia, Czechia
        • ZŠ Rudná
      • Velké Popovice, Czechia, Czechia, 251 69
        • ZŠ Velké Popovice

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Children enrolled in the 3rd grade of participating primary schools
  • Written informed consent from a parent or legal guardian
  • Willingness to participate in study assessments and the school-based intervention

Exclusion Criteria:

  • Acute illness or injury at the time of enrollment or assessment
  • Recovery from illness or injury limiting participation in physical activity
  • Chronic medical condition limiting participation in physical activity
  • Atypical neurodevelopment or diagnosed neurodevelopmental disorder that may affect participation in the intervention or assessments
  • Any other condition judged by the investigators to prevent safe participation in study procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
No Intervention: Control group
Experimental: Interventional 2
intervention 5x a week
Behavioral: E-MOVE - Emotional Movement Program for Physical Education
A school-based physical education intervention delivered through tandem teaching by a physical education teacher and a trained coach five times per week. The program is based on principles of Affective-Reflective Theory (ART) and aims to promote positive affective experiences during physical activity, supporting children's motivation, engagement, and long-term participation in physical activity.
Experimental: Interventional 1
intervention 2x a week
Behavioral: E-MOVE - Emotional Movement Program for Physical Education
A school-based physical education intervention delivered through tandem teaching by a physical education teacher and a trained coach five times per week. The program is based on principles of Affective-Reflective Theory (ART) and aims to promote positive affective experiences during physical activity, supporting children's motivation, engagement, and long-term participation in physical activity.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Cardiorespiratory fitness
Time Frame: Baseline and annually during the 3-year intervention
Cardiorespiratory fitness assessed using the 20-m shuttle run test (Leger test). The outcome was expressed as the number of completed shuttle runs. Higher numbers of completed shuttle runs indicate better cardiorespiratory fitness.
Baseline and annually during the 3-year intervention
Actual Motor Competence
Time Frame: Baseline and annually during the 3-year intervention
Motor competence assessed using the Canadian Agility and Movement Skill Assessment (CAMSA). The Canadian Agility and Movement Skill Assessment (CAMSA) raw score consists of the sum of the skill score and the time score. The skill score and time score each have a maximum of 14 points, yielding a total raw score of 1 to 28. Higher scores indicate better motor competence.
Baseline and annually during the 3-year intervention
Cognitive functions
Time Frame: Baseline and annually during the 3-year intervention
Selected cognitive functions is assessed using the Woodcock-Johnson cognitive test battery. For the present study, results are recommended to be reported as standard scores, which are age-normed with a mean of 100 and a standard deviation of 15. Higher scores indicate better cognitive performance relative to age-matched peers.
Baseline and annually during the 3-year intervention
Physical literacy
Time Frame: Baseline and annually during the 3-year intervention
Physical literacy assessed using the Physical Literacy in Children Questionnaire (PLC-Q). The Physical Literacy in Children Questionnaire (PL-C Quest) consists of 30 items across four domains. Each item is scored on a 1-4-point scale, yielding a total score of 30-120. Higher scores indicate higher self-perceived physical literacy. Thus, higher total scores reflect a higher level of physical literacy.
Baseline and annually during the 3-year intervention
Motivation for physical activity
Time Frame: Baseline and annually during the 3-year intervention
Motivation for participation in physical activity is assessed using the AFFEXX questionnaire. The Affective Exercise Experiences Questionnaire (AFFEXX) consists of 22 items, each rated on a 1-5-point scale, yielding a total score ranging from 22 to 110. Higher scores indicate higher motivation for physical activity.
Baseline and annually during the 3-year intervention
Body composition
Time Frame: Baseline and annually during the 3-year intervention
Body composition is assessed using bioelectrical impedance analysis (BODYSTAT Quadscan 4000). The outcome variables included body fat percentage, intracellular water (ICW), and extracellular water (ECW). Higher body fat values indicate greater adiposity. ICW and ECW represent the relative distribution of body water between the intracellular and extracellular compartments, respectively. Body fat was interpreted using age- and sex-specific percentile cut-offs (<2nd percentile = underfat, 2nd to <85th percentile = normal, 85th to <95th percentile = overfat, and ≥95th percentile = obese), whereas ICW and ECW were interpreted relative to age- and sex-specific reference values, as fixed clinical cut-offs are not established for healthy pediatric populations.
Baseline and annually during the 3-year intervention
Physical activity
Time Frame: Baseline and annually during the 3-year intervention
Physical activity monitored using ActiGraph GT3X accelerometers. Physical activity was objectively assessed using an ActiGraph GT3X accelerometer worn for 7 consecutive days during the week. Data were used to quantify time spent in sedentary behavior, light physical activity (LPA), moderate physical activity (MPA), and vigorous physical activity (VPA). In addition, moderate-to-vigorous physical activity (MVPA) was calculated as the sum of moderate and vigorous physical activity. This 7-day ActiGraph protocol is consistent with common practice in pediatric accelerometer studies. The outcomes were expressed as time spent in each intensity category, typically reported in minutes per day. Sedentary time reflects the amount of time spent inactive, whereas LPA, MPA, VPA, and MVPA reflect increasing levels of movement intensity. Higher values of light, moderate, vigorous, or MVPA indicate that the child is more physically active.
Baseline and annually during the 3-year intervention
Perceived Motor Competence
Time Frame: Baseline and annually during the 3-year intervention
Perceived Motor Competence is assessed using the Pictorial Scale of Perceived Movement Skill Competence (PMSC). The Pictorial Perceived Motor Competence (PMSC) instrument consists of 22 items, with each item rated on a 1-4-point scale. The total score, therefore, ranges from 22 to 88 points. Higher scores indicate higher perceived motor competence.
Baseline and annually during the 3-year intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Charles University, Czech Republic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 11, 2025

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 1, 2028

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 1, 2029

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 13, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 16, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 20, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 20, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 16, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 050824

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings